Your browser doesn't support javascript.
loading
Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study.
Kotulska, Anna; Kucharz, Eugeniusz J; Wiland, Piotr; Olesinska, Marzena; Felis-Giemza, Anna; Kopec-Medrek, Magdalena; Zon-Giebel, Aleksandra; Romanowski, Wojciech; Szymczak-Bartz, Lucyna; Tlustochowicz, Malgorzata; Lewandowicz, Jolanta; Kowalska-Majka, Joanna; Bucka, Jolanta; Majdan, Maria; Kielbik, Zofia; Korkosz, Mariusz; Bielinska, Aneta; Leszczynski, Piotr; Pawlak-Bus, Katarzyna; Puszczewicz, Mariusz J; Majewski, Dominik; Smolik, Katarzyna; Migas-Kukla, Teresa; Sochocka-Bykowska, Malgorzata; Szarecka, Maria; Luberda, Bernadeta; Falenta-Hitnarowicz, Malgorzata; Swikszcz-Gniadek, Jadwiga; Lepiarz-Rusek, Wanda; Rozwadowski, Grzegorz; Chara, Barbara; Zajdel, Jerzy; Zdrojewski, Zbigniew; Maciejowska-Roge, Maria; Rosmus-Kuczia, Irena.
Afiliação
  • Kotulska A; Department of Internal Medicine, Rheumatology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.
  • Kucharz EJ; Department of Internal Medicine, Rheumatology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.
  • Wiland P; Department of Rheumatology and Internal Medicine, Wroclaw Medical University, Wroclaw, Poland.
  • Olesinska M; Department and Clinic of Systemic Connective Tissue Diseases, National Institute of Geriatics, Rheumatology and Rehabilitation, Warsaw, Poland.
  • Felis-Giemza A; Department and Clinic of Systemic Connective Tissue Diseases, National Institute of Geriatics, Rheumatology and Rehabilitation, Warsaw, Poland.
  • Kopec-Medrek M; Department of Internal Medicine, Rheumatology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.
  • Zon-Giebel A; General Jerzy Zietek Silesian Centre of Rheumatology, Rehabilitation and Disability Prevention, Ustron, Poland.
  • Romanowski W; Greater Poland Rheumatological Centre, Srem, Poland.
  • Szymczak-Bartz L; Greater Poland Rheumatological Centre, Srem, Poland.
  • Tlustochowicz M; Department of Internal Medicine and Rheumatology, Military Medical Institute, Warsaw, Poland.
  • Lewandowicz J; Division of Rheumatology, Nicolaus Copernicus Regional Specialist Hospital, Lódz, Poland.
  • Kowalska-Majka J; Division of Rheumatology, Nicolaus Copernicus Regional Specialist Hospital, Lódz, Poland.
  • Bucka J; Division of Rheumatology, Józef Dietl Specialist Hospital, Krakow, Poland.
  • Majdan M; Department of Rheumatology and Systemic Connective Tissue Diseases, Medical University of Lublin, Lublin, Poland.
  • Kielbik Z; Department of Rheumatology and Systemic Connective Tissue Diseases, Medical University of Lublin, Lublin, Poland.
  • Korkosz M; Division of Rheumatology, Department of Internal Medicine and Gerontology, Collegium Medicum, Jagiellonian University, Krakow, Poland.
  • Bielinska A; Division of Rheumatology, Department of Internal Medicine and Gerontology, Collegium Medicum, Jagiellonian University, Krakow, Poland.
  • Leszczynski P; Department of Rheumatology and Rehabilitation, Poznan University of Medical Sciences, Poznan, and Division of Rheumatology and Osteoporosis, Józef Strus Specialist Municipal Hospital, Poznan, Poland.
  • Pawlak-Bus K; Department of Rheumatology and Rehabilitation, Poznan University of Medical Sciences, Poznan, and Division of Rheumatology and Osteoporosis, Józef Strus Specialist Municipal Hospital, Poznan, Poland.
  • Puszczewicz MJ; Department of Rheumatology and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
  • Majewski D; Department of Rheumatology and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
  • Smolik K; Division of Rheumatology, Murcki Hospital, Katowice, Poland.
  • Migas-Kukla T; Division of Rheumatology, Murcki Hospital, Katowice, Poland.
  • Sochocka-Bykowska M; Dr Jadwiga Titz-Kosko Regional Hospital for Rheumatic Disease, Sopot, Poland.
  • Szarecka M; Dr Jadwiga Titz-Kosko Regional Hospital for Rheumatic Disease, Sopot, Poland.
  • Luberda B; Dr Jadwiga Titz-Kosko Regional Hospital for Rheumatic Disease, Sopot, Poland.
  • Falenta-Hitnarowicz M; Division of Rheumatology, Pulmonology and Rheumatology Medical Centre, Kup, Poland.
  • Swikszcz-Gniadek J; Division of Rheumatology, Nicolaus Copernicus Municipal Hospital, Olsztyn, Poland.
  • Lepiarz-Rusek W; Division of Rheumatology, St. Barbara Regional Specialist Hospital, Sosnowiec, Poland.
  • Rozwadowski G; Division of Rheumatology, Lower Silesian Rehabilitation Centre, Kamienna Góra, Poland.
  • Chara B; Division of Rheumatology, Holy Spirit Specialist Hospital, Sandomierz, Poland.
  • Zajdel J; Division of Rheumatology, Regional Specialist Hospital, Czestochowa, Poland.
  • Zdrojewski Z; Department of Internal Medicine, Connective Tissue Diseases and Geriatrics, Medical University of Gdansk, Gdansk, Poland.
  • Maciejowska-Roge M; Division of Rheumatology, Health Care Centre, Wloszczowa, Poland.
  • Rosmus-Kuczia I; First Division of Rheumatology, Hospital for Rheumatology and Rehabilitation, Goczalkowice Zdrój, Poland.
Reumatologia ; 56(3): 140-148, 2018.
Article em En | MEDLINE | ID: mdl-30042601
ABSTRACT

OBJECTIVES:

Biologics are medications widely applied in the management of inflammatory rheumatic diseases. The drugs were found to be effective but their application is associated with some disadvantages. Medication with biologics is relatively expensive, and in Poland, it is carried out in specialized centers. The study was designed to evaluate various aspects of satisfaction and dissatisfaction of Polish patients treated with biologics. MATERIAL AND

METHODS:

An anonymous questionnaire was distributed in 23 Polish rheumatological centers involved in the treatment; 1212 returned questionnaires were used for analysis. Responses were received from 606 patients with rheumatoid arthritis, 427 with ankylosing spondylitis, 117 psoriatic arthritis, and 62 adult patients with juvenile idiopathic arthritis (in whom administration of the drugs had been introduced before they were 18 years old). The investigated group constituted about one-fifth of all rheumatic patients on biologics in Poland.

RESULTS:

A beneficial or very beneficial influence of the medication on the state of physical health was found mostly in patients with rheumatoid arthritis (51.3 and 30.5%) and ankylosing spondylitis (51.0 and 36.8%). Family life was improved by the treatment especially in patients with ankylosing spondylitis (40.7 and 35.6% beneficial and very beneficial, respectively), sleep quality and sexual life mostly in those with ankylosing spondylitis (beneficial/very beneficial influence 41.5/38.4, and 38.7/23.9, respectively). There was a rather small influence of biological treatment on the financial situation of the patients. In general, satisfaction with the treatment was evaluated as positive or very positive in 88% of all investigated patients.In a significant part of the patients, transportation to the medical center was considered as a disadvantage of the treatment. About one-third of the patients considered laboratory and imaging tests to be done before initiation of the medication as a difficulty, and for about 40% waiting time for qualification for the medication was a significant disadvantage. The route of drug administration was without importance for 4/5 of the patients.

CONCLUSIONS:

Summing up, the results were similar in the patients suffering from various diseases although those with psoriatic arthritis felt the highest satisfaction (possibly due to the positive aesthetic effect), and those with ankylosing spondylitis had significant improvement in sexual life (probably due to younger age). Relatively low satisfaction was found in patients with juvenile idiopathic arthritis. There was a small influence of medication on financial status of the patients. Application of biologics has few disadvantages and most of them are associated with the organization of health services (waiting time for the tests, transportation to the medical centers).
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Reumatologia Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Polônia

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Reumatologia Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Polônia